event,time
37 weeks of gestation ,0
    male neonate ,0
    born via caesarean section ,0
    breech presentation ,0
    Apgar score 8 at 1st minute ,0
    Apgar score 9 at 5th minute ,0
    admitted to NICU ,0
    chest retractions ,0
    fever (38.5°C) ,0
    pale ,0
    moderate tachypnoea ,0
    dyspnoea ,0
    bilateral fine gasps ,0
    accentuated bronchovascular markings ,0
    WBC count 11.9 × 109/L ,0
    polymorphonuclear cells 59.4% ,0
    normal C-reactive protein ,0
    sterile blood culture ,0
    RSV type A identified ,0
    nasopharyngeal samples negative for bacteria ,0
"    penicillin 150,000 IU/kg/die ",0
    gentamicin 5 mg/kg/die ,0
    nCPAP started ,0
    increasing fraction of oxygen required ,0
    i.v. systemic corticosteroids ,0
    chest X-ray opacities upper right and hilar-perihilar left lung regions ,24
    antibiotics discontinued ,96
    clinical improvement ,96
    sterile blood culture ,96
    RSV detection in nasopharyngeal samples ,96
    normal procalcitonin levels ,96
    nCPAP replaced with high-flow nasal cannula ,96
    clinical conditions worsened ,168
    severe hypotension ,168
    i.v. fluids ,168
    catecholamine support ,168
    septic shock ,168
    chest X-ray massive opacification right upper and left lower lobes ,168
    hypertrophic interventricular septum ,168
    ampicillin 150 mg/kg/die ,168
    gentamicin 5 mg/kg/die ,168
    cefotaxime 100 mg/kg/die ,168
    nCPAP re-started ,168
    WBC count 23.2 × 109/L ,168
    polymorphonuclear cells 77.7% ,168
    C-reactive protein 15.2 mg/dL ,168
    S. pneumoniae serotype 3 in blood culture ,168
    sterile CSF culture ,168
    i.v. cefotaxime for 10 days ,168
    C-reactive protein normal ,408
    procalcitonin normal ,408
    nCPAP discontinued ,312
    discharged home ,312
    uneventful clinical course ,312
    normal neurodevelopmental outcome at 18 months ,312
